Comment on: Lupus arthritis-do we have a clinically useful classification?

Rheumatology (United Kingdom)

Volumn 51, Issue 8, 2012, Pages 1521-1523

  Amezcua guerra, Luis M ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CITRULLINE;

ARTHRITIS; DISEASE CLASSIFICATION; FOLLOW UP; HUMAN; LETTER; LUPUS ARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ARTHRITIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84865169840     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes138     Document Type: Letter

References (10)

1. Ball EMA, Bell AL. Lupus arthritis-do we have a clinically useful classification? Rheumatology 2012;51:771-9.
2. Amezcua-Guerra LM. Overlap between systemic lupus erythematosus and rheumatoid arthritis: is it real or just an illusion? J Rheumatol 2009;36:4-6.
3. van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 2011;7:391-8.
4. Amezcua-Guerra LM, Springall R, Marquez-Velasco R et al. Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study. Arthritis Res Ther 2006;8:R144.
5. Amezcua-Guerra LM, Marquez-Velasco R, Bojalil R. Erosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anti-cyclic citrullinated peptide antibodies. Inflamm Res 2008;57: 555-7.
6. Chan MT, Owen P, Dunphy J et al. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC class II alleles in systemic lupus erythematosus. J Rheumatol 2008;35:77-83.
7. Kakumanu P, Sobel ES, Narain S et al. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/ erosive arthritis. J Rheumatol 2009;36:2682-90.
8. van der Helm-van Mil AH, Verpoort KN, Breedveld FC et al. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006;54:1117-21.
9. Amezcua-Guerra LM. High-sensitivity C-reactive protein is not a good indicator of infection in patients with systemic lupus erythematosus. Lupus 2011;20:1567-8.
10. Amezcua-Guerra LM, Springall R, Arrieta-Alvarado AA et al. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus. Clin Lab 2011;57:607-13.